Please login to the form below

Not currently logged in
Email:
Password:

BioNTech

This page shows the latest BioNTech news and features for those working in and with pharma, biotech and healthcare.

Newly-listed BioNTech buys Neon to boost cell therapy assets

Newly-listed BioNTech buys Neon to boost cell therapy assets

BioNTech also gets rights to Neon’s neoantigen-hunting platform, which relies on sequencing patients’ tumours. ... In a statement, BioNTech said the deal would give it a US hub for research and clinical development, with Neon operating as a

Latest news

More from news
Approximately 4 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied along with checkpoint inhibitors to see if they can deliver a double-whammy to

  • Deal Watch September 2016 Deal Watch September 2016

    At a lower disclosed headline value of $310m BioNTech licensed its mRNA-based cancer vaccines platform to Genentech. ... The full value cannot be determined as BioNTech received the $310m in upfront and near-term milestone payments, no other financial

  • Deal Watch November 2015 Deal Watch November 2015

    Sanofi will gain access to BioNTech's mRNA formulation technology to generate new cancer immunotherapies. ... Option to US co-promote. 1, 700. BioNTech. Sanofi. Collaboration, licence - multi yr.

  • Pharma deals in May 2015 Pharma deals in May 2015

    This omission was rectified this month as Lilly closed a deal with BioNTech. ... 600. BioNTech/ Lilly. Research collaboration. To identify and validate novel tumour targets and corresponding T cell receptors.

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    BioNTech. German biotech BioNTech has appointed Ryan Richardson(pictured below, right) as chief strategy officer and managing director. ... In his new role, he will support and contribute to the creation and implementation of BioNTech’s long-term growth

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics